Bioverativ develops and commercializes drug therapies for the treatment of hemophilia and other blood disorders.Read more
Baxter is Bioverativ Inc.'s #1 rival. Baxter was founded in 1931 in Deerfield, Illinois. Baxter is in the Health Care Equipment field. Baxter generates $11B more revenue than Bioverativ Inc..
Grifols is one of Bioverativ Inc.'s top competitors. Grifols is headquartered in Barcelona, Barcelona, and was founded in 1909. Grifols competes in the Health Care Equipment field. Grifols generates 557% the revenue of Bioverativ Inc..
September 21, 2021
Medscape Medical News
September 22, 2021
The Business Journals: San Jose
These are all the companies that Bioverativ Inc. has acquired. Bioverativ Inc.'s latest acquisition was True North Therapeutics, Inc. in May 2017. True North is a biotechnology company that engages in research and development of humanized antibodies and novel therapies to treat rare diseases.
No recent funding data found related to Bioverativ Inc.
No recent investments found related to Bioverativ Inc.